Table 2 Elevated metabolic abnormalities and depression in breast cancer survivors

Systolic blood pressure (mmHg)

121 ± 3

122 ± 2

Diastolic blood pressure (mmHg)

68 ± 1

68 ± 1

Hypertension medication usage (%)

43

56

Fasting glucose (mmol/L)

5.2 ± 0.1

5.7 ± 0.2^b

Fasting insulin (pmol/L)

86 ± 7

97 ± 15

HOMA-IR

3.3 ± 0.3

4.1 ± 0.6

2-hr glucose (mmol/L)

7.1 ± 0.4

6.6 ± 0.6

Cholesterol (mmol/L)

4.8 ± 0.1

5.2 ± 0.2^a

Triglycerides (mmol/L)

1.2 ± 0.1

1.4 ± 0.1

HDL-C (mmol/L)

1.4 ± 0.1

1.7 ± 0.1^b

LDL-C (mmol/L)

2.8 ± 0.1

2.9 ± 0.2

Lipid lowering medication usage (%)

11

50^c

Metabolic syndrome components (#)

1.7 ± 0.2

2.4 ± 0.3^b

CES-D

6 ± 1

6 ± 1

Antidepressant medication usage (%)

14

43^b